Marta Seco-Cervera

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Systemic Sclerosis

Long Noncoding Rna

Top Venues

Antioxidants (Basel, Switzerland)

Scientific data

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

José Santiago Ibáñez-Cabellos, Federico V Pallardó, José Luis García-Giménez, Marta Seco-Cervera
Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases. Antioxidants (Basel, Switzerland) 12 (4) (2023)
Lluis Lis-López, Cristina Bauset, Marta Seco-Cervera, Dulce Macias-Ceja, Francisco Navarro, Ángeles Álvarez, Juan Vicente Esplugues, Sara Calatayud, Maria Dolores Barrachina, Dolores Ortiz-Masià, Jesús Cosín-Roger
P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis. International journal of molecular sciences 24 (16) (2023)
José Santiago Ibáñez-Cabellos, Federico V Pallardó, José Luis García-Giménez, Marta Seco-Cervera
Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases. Antioxidants (Basel, Switzerland) 12 (4) (2023)
Cristina Bauset, Lluis Lis-Lopez, Sandra Coll, Laura Gisbert-Ferrándiz, Dulce C Macias-Ceja, Marta Seco-Cervera, Francisco Navarro, Juan V Esplugues, Sara Calatayud, Dolores Ortiz-Masia, Maria D Barrachina, Jesús Cosín-Roger
SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis. Biomedicines 10 (3) (2022)
Dulce C Macias-Ceja, Sandra Coll, Cristina Bauset, Marta Seco-Cervera, Laura Gisbert-Ferrándiz, Francisco Navarro, Jesus Cosin-Roger, Sara Calatayud, María D Barrachina, Dolores Ortiz-Masia
IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn's Disease. Biomedicines 10 (5) (2022)
Lluis Lis-López, Cristina Bauset, Marta Seco-Cervera, Jesús Cosín-Roger
Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines 9 (12) (2021)
Marta Seco-Cervera, Pilar González-Cabo, Federico V Pallardó, Carlos Romá-Mateo, José Luis García-Giménez
Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich's Ataxia. Antioxidants (Basel, Switzerland) 9 (12) (2020)
Marta Seco-Cervera, Dayme González-Rodríguez, José Santiago Ibáñez-Cabellos, Lorena Peiró-Chova, Federico V Pallardó, José Luis García-Giménez
Small RNA-seq analysis of circulating miRNAs to identify phenotypic variability in Friedreich's ataxia patients. Scientific data 5 (2018)